SS Innovations Q3 revenue $12.8M (+192.5% YoY); net loss narrows to $3.7M

SS Innovations International, Inc.

2025-Q3 EPS reported -$0.05 revenue$27,950,264

Revenue $12.8M vs $4.4M YoY; gross profit $6.2M (+166.0%) on 48.1% margin.
SSi Mantra installations 27 in Q3 (up 350% YoY); cumulative installed base 127 in seven countries.
Net loss $3.7M ($0.02/shr) vs $3.2M loss YoY; nine-month loss $9.7M vs $17.2M prior.
FDA 510(k) submission for SSi Mantra expected Q4 2025; CE marking targeted H1 2026.
Appointed Naveen Kumar Amar as CFO in September 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.